Cyclo Therapeutics Inc (CYTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 1,012 | 1,238 | 1,503 | 951 | 1,567 |
| Cost of Goods | 105 | 133 | 198 | 124 | 273 |
| Gross Profit | 907 | 1,105 | 1,305 | 826 | 1,295 |
| Operating Expenses | 5,278 | 5,081 | 5,709 | 3,357 | 2,130 |
| Operating Income | -4,267 | -3,843 | -4,206 | -2,407 | -562 |
| Interest Expense | 0 | 0 | 29 | 31 | 34 |
| Other Income | 12 | 10 | 11 | 7 | 3 |
| Pre-tax Income | -4,255 | -3,833 | -4,224 | -2,431 | -593 |
| Income Tax | N/A | N/A | N/A | 120 | N/A |
| Net Income Continuous | -4,255 | -3,833 | -4,224 | -2,551 | -593 |
| Net Income | $-4,255 | $-3,833 | $-4,224 | $-2,551 | $-593 |
| EPS Basic Total Ops | -5.00 | -5.00 | -7.00 | -5.00 | -1.00 |
| EPS Basic Continuous Ops | -5.20 | -5.32 | -6.67 | -4.54 | -1.17 |
| EPS Diluted Total Ops | -5.00 | -5.00 | -7.00 | -5.00 | -1.00 |
| EPS Diluted Continuous Ops | -5.20 | -5.32 | -6.67 | -4.54 | -1.17 |
| EPS Diluted Before Non-Recurring Items | -5.00 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-4,257 | $-3,834 | $-3,289 | $-2,113 | $-410 |